Home » Topics » Medical technology

Medical technology
RSS

Market for medical products in Latin America is ripe for growth, Part 1 of 2

Aug. 1, 2001

BBI at the Hospitalar 2001 Exhibition, Part 1 of 2

Rigel, Novartis Expand Deal Into Angiogenesis Inhibitors

Aug. 1, 2001

Correction

Aug. 1, 2001

De Novo Raises #17M To Increase Partnerships, Develop Capabilities

Aug. 1, 2001

BioVex Raises #10M In Second Round To Develop Technology

Aug. 1, 2001

Personnel file

Aug. 1, 2001

Business Developments: Cardio sector tops clinical, legal news

Aug. 1, 2001

Glaxo Returning Biota Rights To Next-Generation Flu Product

Aug. 1, 2001

ViroPharma Submits Picovir NDA For Common Cold, Seeks Partner

Aug. 1, 2001

Acquisitions

Aug. 1, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...